The study aims at comparing, in a large cohort of consecutive clinically indicated left atrial appendage closure, clinical and imaging outcomes between different subpopulations.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Primary Safety Endpoint
Timeframe: 7 days
Primary Efficacy Endpoint - Incidence of cardiovascular death, ischemic stroke and systemic embolism
Timeframe: 1 to 5 Years
Secondary Efficacy Endpoint - Incidence of technical success
Timeframe: 7 days to 13 months
Feasibility Endpoint - Total procedure time (min)
Timeframe: During the LAAC Procedure (≃ 60 minutes )
Feasibility Endpoint - dose of contrast medium (ml)
Timeframe: During the LAAC Procedure (≃ 60 minutes )
Feasibility Endpoint - dose of x-ray (cGy.cm2)
Timeframe: During the LAAC Procedure (≃ 60 minutes )
Feasibility Endpoint - number of device implantation attempt during the procedure (number)
Timeframe: During the LAAC Procedure (≃ 60 minutes )
Feasibility Endpoint - number of device change during the procedure (number)
Timeframe: During the LAAC Procedure (≃ 60 minutes )
Net Clinical Benefit Endpoint
Timeframe: 1 to 5 years
LAA patency
Timeframe: 45 days to 13 months
Device related thrombus
Timeframe: 45 days to 13months